Zeo ScientifiX (ZEOX) Cost of Revenue (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Cost of Revenue of $526000.0 for Q2 2026, up 105.47% year-over-year from $256000.0 in Q2 2025, and up 709.23% quarter-over-quarter from $65000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Cost of Revenue (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Cost of Revenue history runs 15 years deep, the most recent figure standing at $526000.0 for Q2 2026.
- In Q2 2026, Cost of Revenue rose 105.47% year-over-year to $526000.0; the TTM figure through Apr 2026 stood at $283000.0 (down 66.63% YoY), while the FY2025 annual figure was $139000.0, down 83.53% from the prior year.
- Cost of Revenue for Q2 2026 stood at $526000.0, up from $65000.0 in the prior quarter.
- The five-year high for Cost of Revenue was $526000.0 in Q2 2026, with the low at -$536000.0 in Q4 2025.
- The 5-year median for Cost of Revenue is $169000.0 (2023), against an average of $157474.1.
- The sharpest annual moves came in 2024 and 2025: Cost of Revenue soared 162.96% in 2024, then slumped 338.22% in 2025.
- Zeo ScientifiX's Cost of Revenue stood at $269247.0 in 2022, then sank by 50.6% to $133000.0 in 2023, then soared by 69.17% to $225000.0 in 2024, then plunged by 338.22% to -$536000.0 in 2025, then jumped by 198.13% to $526000.0 in 2026.
- Business Quant data shows ZEOX's Cost of Revenue at $526000.0 in Q2 2026, $65000.0 in Q1 2026, and -$536000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 298.26 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 387.98 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.21 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 526,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 526,000.00 |
| Apr 30, 2026 | 526,000.00 |
| Jan 31, 2026 | 65,000.00 |
| Jan 31, 2026 | 65,000.00 |
| Oct 31, 2025 | -536,000.00 |
| Oct 31, 2025 | -536,000.00 |
| Jul 31, 2025 | 228,000.00 |
| Jul 31, 2025 | 228,000.00 |
| Apr 30, 2025 | 256,000.00 |
| Apr 30, 2025 | 256,000.00 |
| Jan 31, 2025 | 191,000.00 |
| Jan 31, 2025 | 191,000.00 |
| Oct 31, 2024 | 225,000.00 |
| Oct 31, 2024 | 225,000.00 |
| Jul 31, 2024 | 176,000.00 |
| Jul 31, 2024 | 176,000.00 |
| Apr 30, 2024 | 284,000.00 |
| Apr 30, 2024 | 284,000.00 |
| Jan 31, 2024 | 159,000.00 |
| Jan 31, 2024 | 159,000.00 |